IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Seattle Genetics
Symbol: SGEN
Price: Last trade $41.29
Trade Date: 9/11
Shares: 9.7 million
Underwriter(s) J.P. Morgan, Leerink Partners
Rating=Subscription Needed
Company: USA Compression
Symbol: USAC
Price: Last trade $20.25
Trade Date: 9/10
Shares: 4 million
Underwriter(s) UBS Investment Bank, Wells Fargo Securities, Barclays, Goldman Sachs, J.P. Morgan, Raymond James, RBC Capital Markets
Rating=Subscription Needed
Company: American Midstream Partners
Symbol: AMID
Price: Last trade $11.93
Trade Date: 9/10
Shares: 7.5 million
Underwriter(s) BofA Merrill Lynch, Barclays, Citigroup, Deutsche Bank Securities, RBC Capital Markets, Wells Fargo Securities
Rating=Subscription Needed
Company: La Jolla Pharmaceutical Co.
Symbol: LJPC
Price: Last trade $42.31
Trade Date: 9/10
Shares: 1.9 million
Underwriter(s) Jefferies
Rating=Subscription Needed
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish